Researchers sought to determine risk of venous thromboembolism, based on SAVED and IMPEDE VTE scores, in patients with newly diagnosed multiple myeloma.

Urology and renal transplant patients were excluded (N=43 control, N=34 intervention) from VTE prophylaxis prescribing as the director of urology was unavailable to confirm the scope of the project, ...

Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at an increased risk of developing VTE and are more likely to have a recurrence of VTE and ...

In this comprehensive Review, Drs Stashenko and Tapson examine the literature on the use of venous thromboembolism prophylaxis in hospitalized medical patients, and evaluate the available data for ...

Risk assessment models (RAMs) have been developed to help stratify the risk of VTE among hospitalised patients.10 These models use clinical information from the patient’s history and examination to ...

Extended-duration anticoagulation, compared with standard-duration anticoagulation, for primary VTE prophylaxis in acutely ill medical patients reduced the risk of short-term symptomatic VTE (RR 0.60, ...

“And this was all between 4 and 4:30 p.m. on a Friday, so it saved the patient from having to spend the whole weekend in the hospital,” Brown says. Nurses are uniquely suited to solving the patient ...

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL. Regarding the pediatric ...

Background The association of nursing staffing with patient outcomes has primarily been studied by comparing high to low staffed hospitals, raising concern other factors may account for observed ...

With regard to treatment of VTE, in a retrospective cohort study of 2902 patients with spontaneous ICH, VTE was diagnosed in 3% of the cases, but this complication was independently associated with an ...

To the authors' knowledge, this is the first comprehensive systematic review to describe the generic and disease‐specific patient‐reported outcome measures available for use in venous thromboembolism ...

Overall, 92% of patients in group 3 were provided some form of VTE prophylaxis ( Table 4). This represents better than a 2.7-fold increase in VTE prophylaxis as compared with groups 1 and 2 (34% ...